Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis

Atherosclerosis

Volumn 238, Issue 2, 2015, Pages 321-328

  Jones, Gareth W ^a,b   McLeod, Louise ^a   Kennedy, Catherine L ^a   Bozinovski, Steven ^c   Najdovska, Meri ^a   Jenkins, Brendan J ^a  

^a MONASH UNIVERSITY   (Australia)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ApoE; Atherosclerosis; Gp130; IL 6 family cytokines; STAT3

Indexed keywords

APOLIPOPROTEIN E; CHLORDANE; GLYCOPROTEIN GP 130; SERUM AMYLOID A; STAT3 PROTEIN; TRIACYLGLYCEROL; IL6ST PROTEIN, MOUSE; STAT3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BONE MARROW; CHIMERA; CONTROLLED STUDY; FEMALE; HEART PROTECTION; LIPID BLOOD LEVEL; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; BLOOD; C57BL MOUSE; CHEMOTAXIS; DEFICIENCY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; MUTATION; PATHOLOGY;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHEMOTAXIS; CYTOKINE RECEPTOR GP130; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FEMALE; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; PLAQUE, ATHEROSCLEROTIC; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRIGLYCERIDES;

EID: 84919935152     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.12.037     Document Type: Article

References (35)

1. Dahlöf B. Cardiovascular disease risk factors: epidemiology and risk assessment. Am. J. Cardiol. 2010, 105(Suppl.1). 3A-9A.
2. Plump A.S., Smith J.D., Hayek T., Aalto-Setälä K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. Microbiol. 1992, 71:343-353.
3. Rajamäki K., Lappalained J., Oörni K., Välimäki E., Matikainen S., Kovanen P.T., Eklund K.K. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One. 2010, 5:e11765.
4. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat. Immunol. 2011, 12:204-212.
5. Talayero B.G., Sacks F.M. The role of triglycerides in atherosclerosis. Curr. Cardiol. Rep. 2011, 13:544-552.
6. Mahdy Ali K., Wonnerth A., Huber K., Wojta J. Cardiovascular disease risk reduction by raising HDL cholesterol-current therapies and future opportunities. Br. J. Pharmacol. 2012, 167:1177-1194.
7. Schuett H., Luchtefeld M., Grothusen C., Grote K., Schieffer B. How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb. Haemost. 2009, 102:215-222.
8. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice. J.Exp. Med. 1994, 180:1243-1250.
9. Huber S.A., Sakkinen P., Conze D., Hardin N., Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2364-2367.
10. Luchtefeld M., Schunkert H., Stoll M., Selle T., Lorier R., Grote K., Sagebiel C., Jagavelu K., Tietge U.J., Assmus U., Streetz K., Hengstenberg C., Fischer M., Mayer B., Maresso K., El Mokhtari N.E., Schreiber S., Müller W., Bavendiek U., Grothusen C., Drexler H., Trautwein C., Broeckel U., Schieffer B. Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man. J.Exp. Med. 2007, 204:1935-1944.
11. Song L., Schindler C. IL-6 and the acute phase response in murine atherosclerosis. Atherosclerosis 2004, 177:43-51.
12. Madan M., Bishayi B., Hoge M., Amar S. Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model. Atherosclerosis 2008, 197:504-514.
13. Schieffer B., Selle T., Hilfiker A., Hilfiker-Kleiner D., Grote K., Tietge U.J., Trautwein C., Luchtefeld M., Schmittkamp C., Heeneman S., Daemen M.J., Drexler H. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation. 2004, 110:3493-3500.
14. Heinrich P., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374:1-20.
15. Nicholson S.E., De Souza D., Fabri L.J., Corbin J., Willson T.A., Zhang J.G., Silva A., Asimakis M., Farley A., Nash A.D., Metcalf D., Hilton D.J., Nicola N.A., Baca M. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2 binding site on the shared cytokine receptor subunit gp130. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6493-6498.
16. Khan J.A., Cao M., Kang B.Y., Liu Y., Mehta J.L., Hermonat P.L. AAV/hSTAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol. Atherosclerosis 2010, 213:59-66.
17. Ortiz-Muñoz G., Martin-Ventura J.L., Hernandez-Vargas P., Mallavia B., Lopez-Parra V., Lopez-Franco O., Muñoz-Garcia B., Fernandez-Vizarra P., Ortega L., Egido J., Gomez-Guerrero C. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:525-531.
18. Taleb S., Romain M., Ramkhelawon B., Uyttenhove C., Pasterkamp G., Herbin O., Esposito B., Perez N., Yasukawa H., Van Snick J., Yoshimura A., Tedgui A., Mallat Z. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J.Exp. Med. 2009, 206:2067-2077.
19. Gharavi N.M., Alva J.A., Mouillesseaux K.P., Lai C., Yeh M., Yeung W., Johnson J., Szeto W.L., Hong L., Fishbein M., Wei L., Pfeffer L.M., Berliner J.A. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids invitro and in atherosclerosis invivo. J.Biol. Chem. 2007, 282:31460-31468.
20. Tebbutt N., Giraud A.S., Inglese M., Jenkins B.J., Waring P., Clay F.J., Malki S., Alderman B.M., Grail D., Hollande F., Heath J.K., Ernst M. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 2002, 8:1089-1097.
21. Jenkins B.J., Grail D., Nheu T., Najdovska M., Wang B., Waring P., Inglese M., McLoughlin R.M., Jones S.A., Topley N., Baumann H., Judd L.M., Giraud A.S., Boussioutas A., Zhu H.J., Ernst M. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat. Med. 2005, 11:845-852.
22. Tye H., Kennedy C.L., Najdovska M., McLeod L., McCormack W., Hughes N., Dev A., Sievert W., Ooi C.H., Ishikawa T.O., Oshima H., Bhathal P.S., Parker A.E., Oshima M., Tan P., Jenkins B.J. STAT3-Driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell 2012, 22:466-478.
23. Greenhill C.J., Gould J., Ernst M., Hertzog P.J., Mansell A., Jenkins B.J. LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling. Immunol. Cell Biol. 2012, 90:559-563.
24. Davenport P., Tipping P. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 2003, 163:1117-1125.
25. Kyaw T., Tay C., Hosseini H., Kanellakis P., Gadowski T., MacKay F., Tipping P., Bobik A., Toh B.H. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLoS One. 2012, 7:e29371.
26. Mahdy Ali K., Wonnerth A., Huber K., Wojta J. Cardiovascular disease risk reduction by raising HDL cholesterol-current therapies and future opportunities. Br. J. Pharmacol. 2012, 167:1177-1194.
27. Tomiyama-Hanayama M., Rakugi H., Kohara M., Mima T., Adachi Y., Ohishi M., Katsuya T., Hoshida Y., Aozasa K., Ogihara T., Nishimoto N. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice. Am. J. Physiol. Ren. Physiol. 2009, 297:F679-684.
28. Jenkins B.J., Roberts A.W., Najdovska M., Grail D., Ernst M. The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis. Blood 2005, 105:3512-3520.
29. De Beer M.C., Wroblewski J., Noffsinger V.P., Rateri D.L., Howatt D.A., Balakrishnan A., Ji A., Shridas P., Thompson J.C., van der Westhuyzen D.R., Tannock L.R., Daugherty A., Webb N.R., De Beer F.C. Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2014, 34:255-261.
30. Butcher M.J., Gjurich B., Phillips T., Galkina E.V. The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. Circ. Res. 2012, 110:675-687.
31. Luo W., Bodary P.F., Shen Y., Wickenheiser K.J., Ohman M.K., Guo C., Bahrou K.L., Myers M.G., Eitzman D.T. Leptin receptor-induced STAT3-independent signaling pathways are protective against atherosclerosis in a murine model of obesity and hyperlipidemia. Atherosclerosis 2011, 214:81-85.
32. Schuett H., Oestreich R., Waetzig G.H., Annema W., Luchtefeld M., Hillmer A., Bavendiek U., von Felden J., Divchev D., Kempf T., Wollert K.C., Seegert D., Rose-John S., Tietge U.J., Schieffer B., Grote K. Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 2012, 32:281-290.
33. Thiem S., Pierce T.P., Palmieri M., Putoczki T.L., Buchert M., Preaudet A., Farid R.O., Love C., Catimel B., Lei Z., Rozen S., Gopalakrishnan V., Schaper F., Hallek M., Boussioutas A., Tan P., Jarnicki A., Ernst M. mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. J.Clin. Investig. 2013, 123:767-781.
34. Fernández-Hernando C., Ackah E., Yu J., Suárez Y., Murata T., Iwakiri Y., Prendergast J., Miao R.Q., Birnbaum M.J., Sessa W.C. Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab. 2007, 6:446-457.
35. Ding L., Biswas S., Morton R.E., Smith J.D., Hay N., Byzova T.V., Febbraio M., Podrez E.A. Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice. Cell Metab. 2012, 15:861-872.